Clinical Trials Logo

Filter by:
NCT ID: NCT00621972 Withdrawn - Acute Renal Failure Clinical Trials

AV Fistula Salvage in Advanced CKD Using Sodium Bicarbonate Prophylaxis

Start date: January 2008
Phase:
Study type: Observational

This is an observational study assessing the impact of conventional dose iodinated contrast on the renal function of advanced chronic kidney disease patients undergoing arteriovenous fistula evaluation using a standard sodium bicarbonate prophylaxis protocol. In addition, this model allows for pre and post procedure measurements of kidney function, providing a unique opportunity to assess the utility of novel biomarkers for contrast-induced kidney injury. Our primary hypothesis is that there will be no change in serum creatinine post-procedure when using a standard sodium bicarbonate prophylaxis protocol. Our secondary hypothesis is that there will be no change in urinary kidney-injury marker-1 (KIM-1) post-procedure using a standard sodium bicarbonate prophylaxis protocol. In addition, we will assess the impact of different patient characteristics on the development of contrast-induced kidney injury, such as diabetes, coronary artery disease, hypertension, and angiotensin converting enzyme inhibitor therapy.

NCT ID: NCT00621413 Withdrawn - Prostate Cancer Clinical Trials

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Start date: February 2007
Phase:
Study type: Observational

The purpose of this study is to observe PSA response and incidence of side effects in patients diagnosed with intermediate to high risk prostate cancer and treated with Cesium-131 in combination of external beam therapy.

NCT ID: NCT00621036 Withdrawn - Lymphoma Clinical Trials

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Start date: October 19, 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Vaccines made from a person's cancer proteins may help the body build an effective immune response to kill cancer cells. Colony-stimulating factors, such as GM-CSF, may increase the number of immune cells found in bone marrow or peripheral blood. Giving vaccine therapy together with GM-CSF may make a stronger immune response and kill more cancer cells. PURPOSE: This phase II trial is studying the side effects and how well giving vaccine therapy together with GM-CSF works in treating patients with CNS lymphoma.

NCT ID: NCT00620932 Withdrawn - Prostatectomy Clinical Trials

Exercise Training Among Men With Prostate Cancer

Start date: January 2008
Phase: N/A
Study type: Interventional

The primary objective is to determine the feasibility and acceptability of a home-based endurance exercise program among men diagnosed with clinically localized prostate cancer.

NCT ID: NCT00620737 Withdrawn - Clinical trials for Restrictive Burn Scars of Joint Area

Pilot Safety and Efficacy Study of Isolagen Therapy in Treatment of Restrictive Burn Scars

Start date: February 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety profile and the treatment effect of Isolagen TherapyTM and placebo when administered to stable restrictive burn scars of an affected joint area.

NCT ID: NCT00620607 Withdrawn - Stomach Neoplasms Clinical Trials

huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Start date: May 2007
Phase: Phase 2
Study type: Interventional

To assess the response rate of huC242-DM4 given as an intravenous infusion to patients with metastatic or locally advanced gastric or gastroesophageal junction cancer.

NCT ID: NCT00619580 Withdrawn - Clinical trials for Positive E Coli Infections

Ampicillin-sulbactam Resistant E.Coli at UPMC

Start date: February 2008
Phase: N/A
Study type: Observational

The information collected will optimize the management of patients with gram negative bacteremia. Approximately 300 patients with Gram negative bacteremia are cared for each year at UPMC-P. Published medical literature suggests that mortality from this infection exceeds 20%. The aim of this research is to determine the risk factors for bacteriologic failure of antibiotic therapy, risk factors for antibiotic resistance in bloodstream isolates and risk factors for mortality from Gram negative bacteremia. Modifiable risk factors can then be tackled by a future interventional study.

NCT ID: NCT00618644 Withdrawn - Sickle Cell Anemia Clinical Trials

Ranibizumab for Neovascularization in Sickle Cell Retinopathy

Start date: January 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the ocular and non-ocular safety of a single dose of ranibizumab in treating neovascularization secondary to sickle cell retinopathy.

NCT ID: NCT00617864 Withdrawn - Clinical trials for Ovarian Hyperstimulation Syndrome

The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome

Start date: September 2007
Phase: N/A
Study type: Interventional

This research study was designed to look at the effect of human albumin transfusion on circulating levels of Vascular Endothelial Derived Growth Factor (VEGF), a protein that is believed to be responsible for the syndrome of ovarian hyperstimulation. Patients have been asked to participate because they are identified as at risk for the Ovarian Hyperstimulation Syndrome (OHSS), a potentially serious complication of in vitro fertilization. It has been established that the onset of OHSS may be preventable by the infusion of albumin at the time of egg retrieval; however, we do not know by what mechanism albumin works. As we know the pathogenesis of OHSS is related to VEGF released from the ovaries, we believe human albumin may serve to "bind up" this VEGF and prevent it from causing its harmful effects. The purpose of this study is to evaluate the effect of albumin infusion on blood and urine VEGF levels in these patients.

NCT ID: NCT00617045 Withdrawn - Clinical trials for Major Depressive Disorder

Duloxetine for the Treatment of Postpartum Depression

DuloxPPD
Start date: July 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether the antidepressant, duloxetine, is equally effective as a treatment for subjects who have a Postpartum Onset Depression compared to subjects who have an onset of Major Depressive Disorder prior to delivery. The hypothesis is that duloxetine will be as effective in subjects with Postpartum Major Depressive Disorder as in subjects with a Major Depressive Disorder.